Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[New osteoformative agents for osteoporosis].

¹Fondation Rothschild, service de médecine interne et rhumatologie, Fondation Rothschild, 25, rue Manin, 75940 Paris, France. dchaouat@fo-rothschild.fr

La Revue De Medecine Interne

|October 16, 2002

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Corneal crystalline deposits in monoclonal gammapathy: a report of two cases].

Journal francais d'ophtalmologie·2001

Same author

[Aseptic meningitis after ranitidine treatment for systemic lupus erythematosus].

Presse medicale (Paris, France : 1983)·1999

Same author

Dropped head syndrome. Three case-reports.

Revue du rhumatisme (English ed.)·1999

Same author

[A possible cause of nocturnal leg pain: venous compression of the foramen? letter)].

Presse medicale (Paris, France : 1983)·1999

Same author

[Malignant peritoneal mesothelioma occurring in periodic disease: apropos of a case].

La Revue de medecine interne·1998

Same author

[Local corticosteroid therapy in the treatment of lumbar sciatica].

Presse medicale (Paris, France : 1983)·1998

Same journal

[Atypical low back pain].

La Revue de medecine interne·2026

Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026

Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026

Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026

Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026

Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026

See all related articles

Osteoporosis treatments like parathyroid hormone (PTH) 1-34 show promise in reducing fractures. New osteoformative agents are needed to further increase bone mass and fracture prevention.

Area of Science:

Orthopedics and Endocrinology
Bone Metabolism Research

Context:

Current antiresorptive therapies for osteoporosis have limitations in fracture prevention.
There is a significant need for osteoformative agents to enhance bone mass and reduce fracture risk more effectively.

Purpose:

To review current and emerging osteoformative agents for osteoporosis treatment.
To evaluate the efficacy of parathyroid hormone (PTH) 1-34 and other agents in increasing bone mass and reducing fracture risk.

Summary:

Daily injections of PTH 1-34 have demonstrated increased bone formation and mass, with a randomized study showing reduced vertebral and non-vertebral fractures.
Oral strontium salts show potential for stimulating bone formation and decreasing resorption, requiring further multicenter antifracture studies.
Other agents like statins and fluoride therapy have shown mixed or limited results, while growth factors require further investigation.

Related Experiment Videos

Impact:

Highlights the potential of PTH 1-34 as a key treatment in osteoporosis management.
Identifies promising new therapeutic avenues, such as strontium salts, for substantial fracture risk reduction.
Underscores the ongoing need for research into novel osteoformative agents to address unmet clinical needs in osteoporosis.